18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: A pilot study

Nuclear Medicine Communications

Volumn 35, Issue 12, 2014, Pages 1247-1253

  Kumar, Rakesh ^b   Sharma, Punit ^a,b   Karunanithi, Sellam ^b   Chakraborty, Partha S ^b   Kumar, Rajeev ^b   Seth, Amlesh ^b   Julka, Pramod K ^b   Bal, Chandrasekhar ^b  

^a Eastern Diagnostics India Ltd   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

18F FDG; 18F fluoride; Bone metastasis; Bone scintigraphy; PET CT; Renal cell cancer

Indexed keywords

FLUORINE 18; FLUORIDE; FLUORINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PET-CT SCANNER; PILOT STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BONE NEOPLASMS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; KIDNEY TUMOR; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; SECONDARY;

BONE NEOPLASMS; CARCINOMA, RENAL CELL; FEMALE; FLUORIDES; FLUORINE RADIOISOTOPES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84916638680     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0000000000000195     Document Type: Article

References (23)

1. Seigel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29.
2. Yagoda A, Abi-Rached B, Petrylak D. Chemotherapy for advanced renal-cell carcinoma: 1983-1993. Semin Oncol 1995; 22:42-60.
3. Jung ST, Ghert MA, Harrelson JM, Scully SP. Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res 2003; 409:223-231.
4. Swanson DA, Orovan WL, Johnson DE, Giacco G. Osseous metastases secondary to renal cell carcinoma. Urology 1981; 18:556-561.
5. Fuchs B, Trousdale RT, Rock MG. Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment. Clin Orthop Relat Res 2005; 431:187-192.
6. Motzer RJ, Bacik J, Mazumdar M. Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial Sloan-Kettering cancer center experience. Clin Cancer Res 2004; 10:6302S-6303S.
7. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology Kidney Cancer, version 2, 2012. Available at: http://www.nccn.org/. [Accessed 15 July 2013].
8. Cook GJ, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer 2000; 88:2927-2933.
9. 18F-fluoride: applying new technology to an old tracer. J Nucl Med 2008; 49:68-78.
10. 99mTc-MDP bone scan. Jpn J Radiol 2013; 31:262-269.
11. 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma. Clin Nucl Med 2013; 38:616-621.
12. 18F-fluoride PET/CT in the assessment of multiple myeloma: initial experience. Ann Nucl Med 2013; 27:78-83.
13. Bhargava P, Hanif M, Nash C. Whole-body F-18 sodium fluoride PET-CT in a patient with renal cell carcinoma. Clin Nucl Med 2008; 33:894-895.
14. 18F-Fluoride PET/CT in the detection of bone metastases in clear cell renal cell carcinoma: discordance with bone scintigraphy. Eur J Nucl Med Mol Imaging 2013; 40:1930-1931.
15. Zekri J, Ahmed N, Coleman RE, Hancock BW. The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 2001; 19:379-382.
16. Staudenherz A, Steiner B, Puig S, Kainberger F, Leitha T. Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma? Cancer 1999; 85:153-155.
17. Li Y, Schiepers C, Lake R, Dadparvar S, Berenji GR. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Bone 2012; 50:128-139.
18. Iagaru A, Mittra E, Dick DW, Gambhir SS. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases. Mol Imaging Biol 2012; 14:252-259.
19. Piccardo A, Altrinetti V, Bacigalupo L, Puntoni M, Biscaldi E, Gozza A, et al. Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT Preliminary experience. Eur J Radiol 2012; 81:2632-2638.
20. 18F]FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging 2012; 12:464-474.
21. 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial. J Nucl Med 2013; 54:176-183.
22. 18F-fluoride for PET assessment of metastatic bone disease. Eur J Nucl Med Mol Imaging 2013; 40:1141-1145.
23. Sharma P, Kumar R, Singh H, Bal C, Julka PK, Thulkar S, Malhotra A. Indeterminate lesions on planar bone scintigraphy in lung cancer patients: SPECT, CT or SPECT-CT? Skeletal Radiol 2012; 41:843-850.